American Journal of Therapeutics
Instructions for Authors
Announcement: Effective November 30, 2020 American Journal of Therapeutics will charge a standard fee of $50.00 US for all submissions (excluding revised manuscripts and commissioned articles). The fee covers expenses for the processing and evaluation of your submission by AJT's editorial office.
SCOPE
American Journal of Therapeutics is a clinical pharmacology forum and aims to cover advances in drug therapy, comparative effectiveness research, and post-marketing surveillance.
Manuscript Submission
A submitted manuscript must be an original contribution not previously published (except as an abstract), must not be under consideration for publication elsewhere, and, if accepted, must not be published elsewhere in similar form and in any language. Each person listed as an author is expected to have participated in the study to a significant extent. Although the editors and referees make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the journal, its editors, or the publisher.
On-line Manuscript Submission: All manuscripts must be submitted online through the new Website: http://ajt.edmgr.com.
First-time users: Please click the Register button from the menu and enter the requested information. On successful registration, you will be sent an e-mail indicating your user name and password. Print a copy of this information for future reference. Note: If you have received an e-mail from us with an assigned user ID and password, or if you are a repeat user, do not register again. Just log in. Once you have an assigned ID and password, you do not have to re-register, even if your status changes (that is, author, reviewer, or editor).
Authors: Please click the log-in button from the menu at the top of the page and log into the system as an Author. Submit your manuscript according to the author instructions. You will be able to track the progress of your manuscript through the system. If you experience any problems, please contact the editorial office.
Types of Articles
Original Investigation
Original investigation reports include clinical trials, cohort and case-control studies, risk-benefit assessments, and clinical decision analyses. The text (excluding the title page, tables and references) should not exceed 3000 words. A structured Abstract of 300 words is required and should include the following paragraphs: Background, Study Question, Study Design, Measures and Outcomes, Results, and Conclusions.
Meta-analysis
The data sources must be described in detail and should include in formation published during the year of manuscript preparation. The text (excluding the title page, tables and references) should not exceed 3000 words. A structured Abstract of 300 words is required and should include the following paragraphs: Background, Study Question, Data Sources, Study Design, Results, and Conclusions.
Systematic Review and Clinical Guidelines
These papers will address important management issues in clinical practice. The text (excluding the title page, tables and references) should not exceed 4000 words. A structured Abstract of 300 words is required and should include the following paragraphs: Background, Areas of Uncertainty, Data Sources, Results, and Conclusions.
Manuscripts will be rejected without review if 1) their content does not fit the clinical pharmacology profile of the journal, 2) their abstract, main text, references, figures and tables do not conform to our instructions and 3) they are submitted for the wrong type of article.
The Corresponding Author must provide a list with the names, institutional affiliations and email addresses of 5 potential reviewers. Manuscripts that do not include this list will not be considered for possible publication. The Editor will make a diligent effort to locate reviewers for your work. If suitable reviewers cannot be found within 8 weeks, the manuscript will be rejected.
……
更多详情：
https://edmgr.ovid.com/ajt/accounts/ifauth.htm
